Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 22, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the Company will participate in the following conferences in September.
Citi's 14th Annual Biotech Conference on Wednesday, September 4, 2019, in Boston, MA. The Company will conduct one-on-one meetings with institutional investors at this conference.
Morgan Stanley's 17th Annual Global Healthcare Conference on Tuesday, September 10, 2019, at 11:45 a.m. Eastern Time in New York, NY. The Company will participate in a fireside chat presentation at the conference, which will be webcast live and available for replay in the Investor Relations section of the Portola website (www.portola.com).
About Portola Pharmaceuticals, Inc. Portola Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. The Company's first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya® (andexanet alfa), and Bevyxxa® (betrixaban). The company also is advancing cerdulatinib, a SYK/JAK inhibitor being developed for the treatment of hematologic cancers. Founded in 2003 in South San Francisco, California, Portola has operations in the United States and Europe.
In a landmark collaboration, The emoji company GmbH, in partnership with UNIS Technology Ltd., has announced the development of emoji® branded entertainment centers, under the brand name emojiplanettm. This strategic initiative, brokered by WildBrain...
Sales Focus Inc. (SFI), a global leader in the sales outsourcing industry, has won a Bronze Stevie® Award in the Sales Outsourcing Provider of the Year category in the 2024 Stevie Awards for Sales & Customer...
Finopotamus, the only online resource providing in-depth technology coverage exclusively to credit unions, today announced the launch of the inaugural Payments Industry Leaders Forum (PILF), the second in a Finopotamus series of knowledge portals...
Orchid, a reproductive technology company offering the world's only commercially available whole genome embryo screening, today announced Dr. Amber Cooper, Dr. Roohi Jeelani, and Jerry Lanchbury, Ph.D as new members joining their Medical and...
JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") , one of the largest and most innovative solar module manufacturers in the world, today announced that the Company filed its annual report on Form 20-F for the fiscal year ended December...
Conduent Transportation, a global provider of smart mobility technology solutions and business unit of Conduent Incorporated , today announced the implementation of an Express Lanes tolling system in Virginia. The system, which went live March 17 on...